Autopsy report · NCT01064973

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

“all active subjects were rolled into study 209AS209/NCT01706523”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 10 months before it stopped.
• 32 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Seaside Therapeutics, Inc.

Sponsor type

Industry

Conditions

Autism Spectrum Disorders

Interventions

arbaclofen

Participants

32

Sites

8

Countries

United States

Trials that died the same way

• Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
  “This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07007702.” (65% match in meaning)
• Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
  “All three subjects dosed in the study have rolled over to the Long-Term Follow-up Study IVPRP-LT01 (NCT04628871)” (64% match in meaning)
• The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine
  “No eligible subjects identified. Study closed with IRB.” (63% match in meaning)
• A Global, Prospective, Real-World, Investigation of the Symani® Surgical System for Microsurgical Anastomosis
  “Study replaced by post-approval requirement study NCT06725030” (61% match in meaning)
• Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
  “The number of enrolled subjects did not meet the goal during the study” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.